• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗慢性肾脏病(CKD)患者在透析前阶段及开始血液透析后的血液学特征。

Hematological profile of chronic kidney disease (CKD) patients in Iran, in pre-dialysis stages and after initiation of hemodialysis.

作者信息

Afshar Reza, Sanavi Suzan, Salimi Javad, Ahmadzadeh Mahnaz

机构信息

Nephrology Department, Shahed University, Mustafa Khomeini Hospital, Tehran, Iran.

出版信息

Saudi J Kidney Dis Transpl. 2010 Mar;21(2):368-71.

PMID:20228535
Abstract

Anemia is a common sequealae of chronic kidney disease (CKD), associated with significant morbidity. A cross-sectional study was conducted on 100 CKD patients (54 hemodialyzed, 46 pre-dialyzed). Data including, complete blood count, BUN, creatinine, creatinine clearance, underlying diseases and hemodialysis duration were collected by a questionnaire. The most frequent morphologic features were normochromic-normocytic (80%), hypochromic-microcytic (15%) and macrocytic (5%). The frequency of anemia in hemodialyzed and pre-dialyzed patients (with mean Hgb level of 10.27 and 11.11 g/dL) were 85% and 75%. Hemoglobin concentration was positively correlated to calculated creatinine clearance (P < 0.001). The severity of anemia among hemodialyzed patients was mild (Hgb > 10 g/dL) in 5%, moderate in 70% and severe (Hgb < 7 g/dL) in 25%, while in pre-dialyzed was mild in 45% and moderate in 55%. There was no correlation between the anemia and CKD causes or hemodialysis duration. In conclusion, data shows that anemia in our patients with CKD is a predominant manifestation, with high frequency but of moderate degree. The most likely cause is inadequate erythropoietin production.

摘要

贫血是慢性肾脏病(CKD)常见的后遗症,与显著的发病率相关。对100例CKD患者(54例接受血液透析,46例未透析)进行了一项横断面研究。通过问卷调查收集包括全血细胞计数、血尿素氮、肌酐、肌酐清除率、基础疾病和血液透析时间等数据。最常见的形态学特征为正色素正细胞性(80%)、低色素小细胞性(15%)和大细胞性(5%)。血液透析患者和未透析患者贫血的发生率(平均血红蛋白水平分别为10.27 g/dL和11.11 g/dL)分别为85%和75%。血红蛋白浓度与计算的肌酐清除率呈正相关(P < 0.001)。血液透析患者中,5%的患者贫血程度为轻度(血红蛋白>10 g/dL),70%为中度,25%为重度(血红蛋白<7 g/dL);而未透析患者中,45%为轻度,55%为中度。贫血与CKD病因或血液透析时间无关。总之,数据表明,我们的CKD患者贫血是主要表现,发生率高但程度中等。最可能的原因是促红细胞生成素产生不足。

相似文献

1
Hematological profile of chronic kidney disease (CKD) patients in Iran, in pre-dialysis stages and after initiation of hemodialysis.伊朗慢性肾脏病(CKD)患者在透析前阶段及开始血液透析后的血液学特征。
Saudi J Kidney Dis Transpl. 2010 Mar;21(2):368-71.
2
Prevalence and severity of anemia in pediatric hemodialysis patients.小儿血液透析患者贫血的患病率及严重程度
Saudi Med J. 2007 Feb;28(2):249-53.
3
Health-related quality of life and hemoglobin levels in chronic kidney disease patients.慢性肾病患者的健康相关生活质量与血红蛋白水平
Clin J Am Soc Nephrol. 2009 Jan;4(1):33-8. doi: 10.2215/CJN.00630208. Epub 2008 Nov 5.
4
Effect of variability in anemia management on hemoglobin outcomes in ESRD.终末期肾病患者贫血管理的变异性对血红蛋白结果的影响。
Am J Kidney Dis. 2003 Jan;41(1):111-24. doi: 10.1053/ajkd.2003.50030.
5
The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.持续促红细胞生成素受体激活剂(C.E.R.A.)在延长给药间隔时可纠正未接受透析的慢性肾病患者的贫血:一项II期研究结果
Clin Nephrol. 2007 May;67(5):306-17.
6
[Prevalence of mild to moderate chronic kidney disease in the general population of Spain. Hortega study].[西班牙普通人群中轻度至中度慢性肾脏病的患病率。奥尔特加研究]
Nefrologia. 2004;24(4):329-32, 334, 336-7.
7
Role of erythropoietin in anemia after heart transplantation.促红细胞生成素在心脏移植后贫血中的作用。
Int J Cardiol. 2006 Oct 10;112(3):341-7. doi: 10.1016/j.ijcard.2005.10.007. Epub 2005 Nov 23.
8
Detection and awareness of moderate to advanced CKD by primary care practitioners: a cross-sectional study from Italy.初级保健医生对中度至重度慢性肾脏病的检测与认知:一项来自意大利的横断面研究
Am J Kidney Dis. 2008 Sep;52(3):444-53. doi: 10.1053/j.ajkd.2008.03.002. Epub 2008 May 12.
9
Factors affecting anemia management in hemodialysis patients: a single-center experience.影响血液透析患者贫血管理的因素:单中心经验
Hemodial Int. 2008 Jul;12(3):336-41. doi: 10.1111/j.1542-4758.2008.00278.x.
10
Phagocytic polymorphonuclear function in patients with progressive uremia and the effect of acute hemodialysis.进展性尿毒症患者的吞噬性多形核白细胞功能及急性血液透析的影响
Ren Fail. 2005;27(4):357-60.

引用本文的文献

1
Assessment of the hematological profile of children with chronic kidney disease on follow-up at St. Paul's Hospital Millennium Medical College and Tikur Anbessa Specialized Hospital in Addis Ababa, Ethiopia.评估埃塞俄比亚亚的斯亚贝巴圣保罗医院千年医科大学和提克努尔安贝萨专科医院接受随访的慢性肾脏病儿童的血液学特征。
BMC Nephrol. 2024 Jan 30;25(1):44. doi: 10.1186/s12882-024-03464-7.
2
Efficiency of Platelet Transfusion in Patients with Moderate-to-Severe Chronic Kidney Disease and Thrombocytopenia.血小板输注治疗中重度慢性肾脏病伴血小板减少症患者的疗效。
Int J Mol Sci. 2023 Nov 2;24(21):15895. doi: 10.3390/ijms242115895.
3
Hematological Abnormalities and Comorbidities Are Associated With the Severity of Kidney Disease: A Hospital-Based Cross-Sectional Study in Bangladesh.
血液学异常和合并症与肾脏疾病的严重程度相关:孟加拉国一项基于医院的横断面研究
Clin Pathol. 2022 Jul 23;15:2632010X221114807. doi: 10.1177/2632010X221114807. eCollection 2022 Jan-Dec.
4
Risk Factors for Anemia in Patients with Chronic Renal Failure: A Systematic Review and Meta-Analysis.慢性肾衰竭患者贫血的危险因素:系统评价和荟萃分析。
Ethiop J Health Sci. 2020 Sep;30(5):829-842. doi: 10.4314/ejhs.v30i5.23.
5
Haematological profile of chronic kidney disease in a mixed-ancestry South African population: a cross-sectional study.南非混合血统人群慢性肾脏病的血液学特征:一项横断面研究。
BMJ Open. 2018 Nov 3;8(11):e025694. doi: 10.1136/bmjopen-2018-025694.
6
Frequency of Specific Cardiovascular Disease Risk Factors among Cameroonian Patients on Dialysis: The Cases of Anaemia, Inflammation, Phosphate, and Calcium.喀麦隆透析患者特定心血管疾病风险因素的频率:贫血、炎症、磷酸盐和钙的情况
Cardiol Res Pract. 2016;2016:5031927. doi: 10.1155/2016/5031927. Epub 2016 May 22.
7
Renal Function and Hematology in Rats with Congenital Renal Hypoplasia.先天性肾发育不全大鼠的肾功能与血液学
Comp Med. 2016 Feb;66(1):10-20.
8
Anemia in patients on chronic hemodialysis in Cameroon: prevalence, characteristics and management in low resources setting.喀麦隆慢性血液透析患者的贫血:资源匮乏地区的患病率、特征及管理
Afr Health Sci. 2015 Mar;15(1):253-60. doi: 10.4314/ahs.v15i1.33.
9
Haemodialysis in an emerging centre in a developing country: a two year review and predictors of mortality.发展中国家新兴中心的血液透析:两年回顾及死亡率的预测因素。
BMC Nephrol. 2011 Oct 2;12:50. doi: 10.1186/1471-2369-12-50.
10
Macrocytosis may be associated with mortality in chronic hemodialysis patients: a prospective study.巨红细胞症可能与慢性血液透析患者的死亡率相关:一项前瞻性研究。
BMC Nephrol. 2011 May 11;12:19. doi: 10.1186/1471-2369-12-19.